Aortic valve replacement study for severe stenosis
Part of Heart & circulation clinical trials.
This study tracks patients getting a new heart valve (transcatheter aortic valve implantation) for severe aortic stenosis. It aims to understand long-term outcomes and safety in a real-world registry.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been told you have aortic stenosis, a narrowing of your heart's aortic valve.
- Your aortic stenosis is severe and either from wear and tear as you age or a condition you were born with.
- You have symptoms like chest pain, shortness of breath, or fatigue, rated as New York Heart Association class 2 or higher.
- You have not had a stroke or mini-stroke in the last 3 months.
- You do not have an active infection inside your heart called endocarditis.
- You signed a form agreeing to be in the study before the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new replacement valve for the aortic heart valve, delivered through a catheter (a thin tube) — a procedure called TAVR. It is for people who have severe aortic stenosis and are not good candidates for open-heart surgery.
This study tests a new replacement valve for the aortic valve, which controls blood flow from the heart. It may help people with severe aortic valve narrowing or leaking who need surgery.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
This trial tests a minimally invasive procedure to replace a narrowed heart valve in emergency situations, such as cardiac arrest or severe heart failure. It aims to help people who are too sick for standard treatments and need immediate care.
This trial is testing a new, less invasive way to replace a narrowed aortic valve using a special device. The goal is to help improve blood flow and reduce symptoms like chest pain and shortness of breath.
This trial tests a new valve device placed through a small tube (catheter) to treat severe aortic stenosis, a condition where the aortic valve is narrowed and doesn't open fully. It's for patients who cannot have traditional open-heart surgery.
Hear when a new Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.